GlassScriptPhysician profile
Michael Austin Brooks
NPI 1861760969
$46,947.41
in general payments reported to CMS, 2019-2025
40 companies · $7,068 in 2025
The $7,068 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $201 · 2021: $198 · 2022: $2,580 · 2023: $14K · 2024: $22K · 2025: $7,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $33K · Travel and Lodging: $4,596 · Food and Beverage: $4,572 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $33,000.00 |
| Travel and Lodging | $4,596.44 |
| Food and Beverage | $4,571.63 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $42,323.15 | 2022-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Coloplast Corp | $782.61 | 2019-2025 | Coloplast Tfl Drive, Porges Coloplast, Isiris Astent Removal Device |
| Boston Scientific Corporation | $586.75 | 2021-2025 | Moses 550 Dfl, Rezum Generator, Axonics |
| Pfizer INC. | $409.80 | 2022-2025 | |
| Astellas Pharma US INC | $202.93 | 2021-2025 | Xtandi |
| Immunitybio, INC. | $180.15 | 2024 | |
| Angiodynamics, INC. | $160.24 | 2022-2023 | Nanoknife |
| Merck Sharp & Dohme LLC | $155.36 | 2022-2025 | Keytruda |
| Ethicon US, LLC | $145.08 | 2021-2025 | Evarrest, Vistaseal, Ethicon |
| Janssen Biotech, INC. | $143.80 | 2024-2025 | Erleada, Akeega |
| Koelis INC. | $138.01 | 2023 | |
| Endo Pharmaceuticals INC. | $134.49 | 2022 | |
| Biotissue Holdings INC. | $132.50 | 2023-2025 | |
| Endo USA, INC. | $124.33 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $103.93 | 2024-2025 | Adstiladrin |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $99.52 | 2024 | |
| Zimvie INC. | $99.00 | 2022 | |
| Abc Home Medical Supply, INC. | $93.82 | 2022-2025 | |
| Myovant Sciences INC. | $88.33 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $84.64 | 2022-2023 | Prolaris |
| Tolmar, INC. | $66.40 | 2023-2025 | Eligard, Jatenzo |
| Ambu INC. | $62.63 | 2021-2025 | |
| Procept Biorobotics Corporation | $58.50 | 2019-2022 | |
| Novo Nordisk INC | $55.11 | 2024-2025 | Rivfloza |
| Urogen Pharma, INC. | $52.17 | 2024-2025 | |
| Convatec INC. | $47.51 | 2022-2023 | |
| Hollister Incorporated | $46.21 | 2023 | Vapro Plus Pocket, Infyna Chic, Onli |
| Edap Technomed INC | $42.58 | 2022 | |
| Teleflex LLC | $39.78 | 2023 | Urolift |
| Sumitomo Pharma America, INC. | $39.51 | 2024 | Orgovyx |
| Medtronic USA, INC. | $38.70 | 2020 | |
| Photocure INC | $34.34 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $27.30 | 2025 | Exparel, Iovera |
| 180 Medical, INC. | $25.54 | 2025 | |
| Progenics Pharmaceuticals, INC. | $25.10 | 2021 | |
| Medtronic, INC. | $22.92 | 2023 | Signia |
| Axonics, INC. | $21.36 | 2024 | Axonics |
| Heron Therapeutics, INC. | $20.76 | 2025 | Zynrelef |
| Abbvie INC. | $17.91 | 2023 | Lupron Depot |
| Halozyme INC | $14.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.